Estepan Ian Michael

Insider profile

Performance

Overall performance
3.5

Performance over holding periods
3.5
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 88% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Estepan Ian Michael's trades of Sarepta Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-12-18 2025-12-16 S Sale
13,586 +21.6%
53.15
US$4,294,057
13,586 +21.6% 53.15 US$4,294,057
2025-12-16 2025-12-16 PrS Proposed sale
20,619
224.11
US$1,340,407
20,619 224.11 US$1,340,407
2024-09-03 2024-08-30 S Sale
4,607 -25.3%
24.32
US$2,631,296
4,607 -25.3% 24.32 US$2,631,296
2024-08-30 2024-08-30 PrS Proposed sale
5,985
137.37
US$822,130
5,985 137.37 US$822,130
2024-03-05 2024-03-01 S Sale
1,200 -3.0%
128.30
US$153,960
1,200 -3.0% 128.30 US$153,960
2024-03-01 2024-03-01 PrS Proposed sale
1,565
127.81
US$200,020
1,565 127.81 US$200,020